相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma
Xiao X. Wei et al.
JOURNAL OF UROLOGY (2021)
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Matthew D. Galsky et al.
LANCET (2020)
Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361
A. Alva et al.
ANNALS OF ONCOLOGY (2020)
Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options
Maria Koufopoulou et al.
CANCER TREATMENT REVIEWS (2020)
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Thomas Powles et al.
LANCET ONCOLOGY (2020)
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)
Gurjyot K. Doshi et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2020)
Treatment patterns and overall survival in metastatic urothelial carcinoma in a real-world, US setting
Jason C. Simeone et al.
CANCER EPIDEMIOLOGY (2019)
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
Emily Feld et al.
EUROPEAN UROLOGY (2019)
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition
Arlene Siefker-Radtke et al.
NATURE REVIEWS UROLOGY (2018)
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
Pedro C. Barata et al.
TARGETED ONCOLOGY (2018)
Recent developments in the treatment of advanced bladder cancer
James Luke Godwin et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Immune Checkpoint Inhibition in Metastatic Urothelial Cancer
Tom Powles et al.
EUROPEAN UROLOGY (2017)
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
M. D. Galsky et al.
ANNALS OF ONCOLOGY (2012)
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
Maria De Santis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
Luigi Dogliotti et al.
EUROPEAN UROLOGY (2007)
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder
Atreya Dash et al.
CANCER (2006)
分享论文
